[1]
|
Shahid, I., AlMalki, W., Hafeez, M. and Hassan, S. (2014) Hepatitis C Virus Infection Treatment: An Era of Game Changer Direct Acting Antivirals and Novel Treatment Strategies. Critical Reviews in Microbiology, 6, 1-13. http://dx.doi.org/10.3109/1040841X.2014.970123
|
[2]
|
Shahid, I., Ahmad, W., Ijaz, B., Javed, F.T., Gull, S., Kausar, H., Sarwar, M.T., Asad, S., Sumrin, A., Khaliq, S., Jahan, S., Pervaiz, A. and Hassan, S. (2013) Stable Huh-7 Cell Line Development Expressing HCV Non-Structural Proteins of Genotype 1a. Journal of Virological Methods, 4, 4.
|
[3]
|
Asad, S., Ijaz, B., Ahmad, W., Kausar, H., Sarwar, T., Gull, S., Shahid, I., Khan, M. and Hassan S. (2012) Development of Persistent HCV Genotype 3a Infection Cell Culture Model in Huh-7 Cell. Virology Journal, 9, 11. http://dx.doi.org/10.1186/1743-422X-9-11
|
[4]
|
Ansar, M., Ashfaq, U.A., Shahid, I., Sarwar, T., Javed, T., Rehman, S., Hassan, S. and Riazuddin S. (2011) Inhibition of Full Length Hepatitis C Virus Particles of 1a Genotype through Small Interference RNA. Virology Journal, 8, 203. http://dx.doi.org/10.1186/1743-422X-8-203
|
[5]
|
Ahmad, W., Ijaz, B., Javed, F.T., Jahan, S., Shahid, I., Khan, M. and Hassan S. (2010) HCV Genotype Distribution and Possible Transmission Risks in Lahore, Pakistan. World Journal of Gastroenterology, 16, 4321-4328. http://dx.doi.org/10.3748/wjg.v16.i34.4321
|
[6]
|
Ahmad, W., Shabbiri, K., Ijaz, B., Asad, S., Sarwar, M.T., Gull, S., Kausar, H., Fouzia, K., Shahid, I. and Hassan S. (2011) Claudin-1 Required for HCV Virus Entry Has High Potential for Phosphorylation and O-Glycosylation. Virology Journal, 8, 229. http://dx.doi.org/10.1186/1743-422X-8-229
|
[7]
|
Sarwar, M.T., Kausar, H., Ijaz, B., Ahmad, W., Ansar, M., Sumrin, A., Ashfaq, U.A., Asad, S., Gull, S., Shahid, I. and Hassan S. (2011) NS4A Protein as a Marker of HCV History Suggests that Different HCV Genotypes Originally Evolved from Genotype 1b. Virology Journal, 8, 317. http://dx.doi.org/10.1186/1743-422X-8-317
|
[8]
|
Lazaro, A., Chang, M., Tang, W., Campbell, J., Sullivan, G., Gretch, R., Corey, L., Coombs, W. and Fausto N. (2007) Hepatitis C Virus Replication in Transfected and Serum-Infected Cultured Human Fetal Hepatocytes. American Journal of Pathology, 170, 478-489. http://dx.doi.org/10.2353/ajpath.2007.060789
|
[9]
|
Butt, S., Idrees, M., Rehman, U., Ali, L., Hussain, A., Ali, M., Ahmed, N., Saleem, S. and Fayyaz M. (2011) Establishment of Stable Huh-7 Cell Lines Expressing Various Hepatitis C Virus Genotype 3a Protein: An In-Vitro Testing System for Novel Anti-HCV Drugs. Genetics Vaccines Therapy, 9, 12-17. http://dx.doi.org/10.1186/1479-0556-9-12
|
[10]
|
Buck, M. (2008) Direct Infection and Replication of Naturally Occurring Hepatitis C Virus Genotypes 1, 2, 3 and 4 in Normal Human Hepatocyte Cultures. PLoS One, 3, e2660. http://dx.doi.org/10.1371/journal.pone.0002660
|
[11]
|
Molina, S., Castet, V., Pichard-Garcia, L., Wychowski, C., Meurs, E., Pascussi, M., Sureau, C., Fabre, M., Sacunha, A. and Larrey, D. (2008) Serum-Derived Hepatitis C Virus Infection of Primary Human Hepatocytes Is Tetraspanin CD81 Dependent. Journal of Virology, 82, 569-574. http://dx.doi.org/10.1128/JVI.01443-07
|
[12]
|
Lisowski, L., Elazar, M., Chu, K., Glenn, J. and Kay, M. (2013) The Anti-Genomic (Negative) Strand of Hepatitis C Virus Is Not Targetable by shRNA. Nucleic Acids Research, 41, 3688-3698. http://dx.doi.org/10.1093/nar/gkt068
|
[13]
|
Zheng, D., Giljohann, A. and Chen, L. (2012) Topical Delivery of siRNA-Based Spherical Nucleic Acid Nanoparticle Conjugates for Gene Regulation. Proceedings of the National Academy of Sciences of the United States of America, 109, 11975-11980. http://dx.doi.org/10.1073/pnas.1118425109
|
[14]
|
Gao, K., and Huang, L. (2009) Nonviral Methods for siRNA Delivery. Molecular Pharmacology, 6, 651-658. http://dx.doi.org/10.1021/mp800134q
|
[15]
|
Zintchenko, A., Philipp, A., Dehshahri, A. and Wagner, E. (2008) Simple Modifications of Branched PEI Lead to Highly Efficient siRNA Carriers with Low Toxicity. Bioconjugation Chemistry, 19, 1448-1455. http://dx.doi.org/10.1021/bc800065f
|
[16]
|
Caplen, J., Parrish, S., Imani, F., Fire, A. and Morgan, A. (2001) Specific Inhibition of Gene Expression by Small Double-Stranded RNAs in Invertebrate and Vertebrate Systems. Proceedings of the National Academy of Sciences of the United States of America, 98, 9742-9747. http://dx.doi.org/10.1073/pnas.171251798
|
[17]
|
Coburn, A. and Cullen, R. (2002) Potent and Specific Inhibition of Human Immunodeficiency Virus Type 1 Replication by RNA Interference. Journal of Virology, 76, 9225-9231. http://dx.doi.org/10.1128/JVI.76.18.9225-9231.2002
|
[18]
|
Brummelkamp, R., Bernards, R. and Agami, R. (2002) Stable Suppression of Tumorigenicity by Virus-Mediated RNA Interference. Cancer Cell, 2, 243-247. http://dx.doi.org/10.1016/S1535-6108(02)00122-8
|
[19]
|
Hannon, J. (2002) RNA Interference. Nature, 418, 244-251. http://dx.doi.org/10.1038/418244a
|
[20]
|
Korf, M., Meyer, A., Jarczak, D., Beger, C., Manns, P. and Kruger, M. (2007) Inhibition of HCV Subgenomic Replicons by siRNAs Derived from Plasmids with Opposing U6 and H1 Promoters. Journal of Viral Hepatology, 14, 122-132. http://dx.doi.org/10.1111/j.1365-2893.2006.00793.x
|
[21]
|
Seo, Y., Abrignani, S., Houghton, M. and Han, H. (2003) Small Interfering RNA-Mediated Inhibition of Hepatitis C Virus Replication in the Human Hepatoma Cell Line Huh-7. Journal of Virology, 77, 810-812. http://dx.doi.org/10.1128/JVI.77.1.810-812.2003
|
[22]
|
Khaliq, S., Jahan, S., Ijaz, B., Ahmad, W., Asad, S. and Hassan, S. (2011) Inhibition of Hepatitis C Virus Genotype 3a by siRNAs Targeting Envelope Genes. Archives of Virology, 156, 433-442. http://dx.doi.org/10.1007/s00705-010-0887-6
|
[23]
|
Zekri, R., Bahnassy, A., El-Din, M. and Salama, M. (2009) Consensus siRNA for Inhibition of HCV Genotype-4 Replication. Virology Journal, 6, 13. http://dx.doi.org/10.1186/1743-422X-6-13
|
[24]
|
Shin, D., Lee, H., Kim, I., Yoon, Y. and Kim M. (2009) Optimization of Linear Double-Stranded RNA for the Production of Multiple siRNAs Targeting Hepatitis C Virus. RNA, 15, 898-910. http://dx.doi.org/10.1261/rna.1268209
|
[25]
|
Khaliq, S., Jahan, S., Ijaz, B., Ahmad, W., Asad, S., Pervaiz, A., Samreen, B., Khan, M. and Hassan, S. (2010) Inhibition of Core Gene of HCV 3a Genotype Using Synthetic and Vector Derived siRNAs. Virology Journal, 7, 318. http://dx.doi.org/10.1186/1743-422X-7-318
|
[26]
|
Ahmad, W., Ijaz, B., Javed, T., Kausar, H., Sarwar, M.T., Gull, S., Asad, S., Shahid, I. and Hassan, S. (2011) HCV Genotype-Specific Correlation with Serum Markers: Higher Predictability for Genotype 4a. Virology Journal, 8, 293. http://dx.doi.org/10.1186/1743-422X-8-293
|
[27]
|
Grimm, S. (2004) The Art and Design of Genetic Screens: Mammalian Culture Cells. Nature Reviews in Genetics, 5, 179-189. http://dx.doi.org/10.1038/nrg1291
|
[28]
|
Wurm, M. (2004) Production of Recombinant Protein Therapeutics in Cultivated Mammalian Cells. Nature Biotechnology, 22, 1393-1398. http://dx.doi.org/10.1038/nbt1026
|
[29]
|
Jarczak, D., Korf, M., Beger, C., Manns, P. and Kruger, M. (2005) Hairpin Ribozymes in Combination with siRNAs against Highly Conserved Hepatitis C Virus Sequence Inhibit RNA Replication and Protein Translation from Hepatitis C Virus Subgenomic Replicons. FEBS Journal, 272, 5910-5922. http://dx.doi.org/10.1111/j.1742-4658.2005.04986.x
|
[30]
|
Kim, M., Shin, D., Kim, S. and Park, M. (2006) Inhibition of Hepatitis C Virus Gene Expression by Small Interfering RNAs Using a Tri-Cistronic Full-Length Viral Replicon and a Transient Mouse Model. Virus Research, 122, 1-10. http://dx.doi.org/10.1016/j.virusres.2006.05.003
|
[31]
|
Liu, M., Ding, H., Zhou, P., Qin, L., Gao, J., Cao, M., Luan, J., Wu, B. and Qi, T. (2006) RNA Interference Effectively Inhibits mRNA Accumulation and Protein Expression of Hepatitis C Virus Core and E2 Genes in Human Cells. Bioscience Biotechnology and Biochemistry, 70, 2049-2055. http://dx.doi.org/10.1271/bbb.60001
|
[32]
|
Grakoui, A., McCourt, W., Wychowski, C., Feinstone, M. and Rice, M. (1993) Characterization of the Hepatitis C Virus-Encoded Serine Proteinase: Determination of Proteinase-Dependent Polyprotein Cleavage Sites. Journal of Virology, 67, 2832-2843.
|
[33]
|
Bartenschlager, R., Lohmann, V., Wilkinson, T. and Koch, O. (1995) Complex Formation between the NS3 Serine-Type Proteinase of the Hepatitis C Virus and NS4A and Its Importance for Polyprotein Maturation. Journal of Virology, 69, 7519-7528.
|
[34]
|
Tanji, Y., Hijikata, M., Satoh, S., Kaneko, T. and Shimotohno, K. (1995) Hepatitis C Virus Encoded Non-Structural Protein NS4A Has Versatile Functions in Viral Protein Processing. Journal of Virology, 69, 1575-1581.
|
[35]
|
Macdonald, A., Crowder, K., Street, A., McCormick, C. and Harris, M. (2004) The Hepatitis C Virus NS5A Protein Binds to Members of the Src Family of Tyrosine Kinases and Regulates Kinase Activity. Journal of General Virology, 85, 721-729. http://dx.doi.org/10.1099/vir.0.19691-0
|
[36]
|
Reed, E., Xu, J. and Rice, M. (1997) Phosphorylation of the Hepatitis C Virus NS5A Protein in Vitro and in Vivo: Properties of the NS5A-Associated Kinase. Journal of Virology, 71, 7187-7197.
|
[37]
|
Tan, L. and Katze, G. 92001) How Hepatitis C Virus Counteracts the Interferon Response: The Jury Is Still Out on NS5A. Virology, 284, 1-12. http://dx.doi.org/10.1006/viro.2001.0885
|
[38]
|
Gale, J., Korth, M.J., Tang, M., Tan, L., Hopkins, A., Dever, E., Polyak, J., Gretch, R. and Katze, G. (1997) Evidence That Hepatitis C Virus Resistance to Interferon Is Mediated through Repression of the PKR Protein Kinase by the Non-Structural 5A Protein. Virology, 230, 217-227. http://dx.doi.org/10.1006/viro.1997.8493
|
[39]
|
El-Awardy, K., Tabll, A., El-Abd, S., Bahgat, M., Shoeb, A., Youssef, S., El-Din, B., Redwan, M., El-Demellawy, M., Omran, H., El-Garf, T. and Goueli, A. (2006) HepG2 Cells Support Viral Replication and Gene Expression of Hepatitis C Virus Genotype 4 in Vitro. World Journal of Gastroenterology, 12, 4836-4842.
|
[40]
|
Lazaro, A., Chang, M., Tang, W., Campbell, J., Sullivan, G., Gretch, D., Corey, L., Coombs, W. and Fausto, N. (2007) Hepatitis C Virus Replication in Transfected and Serum-Infected Cultured Human Fetal Hepatocytes. American Journal of Pathology, 170, 478-489. http://dx.doi.org/10.2353/ajpath.2007.060789
|
[41]
|
Guha, C., Lee, W., Chowdhury, R. and Chowdhury, J. (2005) Cell Culture Models and Animal Models of Viral Hepatitis. Part II: Hepatitis C. Laboratory Animals, 34, 39-47. http://dx.doi.org/10.1038/laban0205-39
|
[42]
|
Kanda, T., Steele, R., Ray, R. and Ray, B. (2007) Small Interfering RNA Targeted to Hepatitis C Virus 5’ Nontranslated Region Exerts a Potent Antiviral Effect. Journal of Virology, 81, 669-676. http://dx.doi.org/10.1128/JVI.01496-06
|
[43]
|
Kapadia, B., Brideau-Andersen, A. and Chisari, V. (2003) Interference of Hepatitis C Virus RNA Replication by Short Interfering RNAs. Proceedings of the National Academy of Sciences of the United States of America, 100, 2014-2018. http://dx.doi.org/10.1073/pnas.252783999
|
[44]
|
McCaffrey, P., Mause, L., Pham, T., Conklin, S., Hannon, J. and Kay, A. (2002) RNA Interference in Adult Mice. Nature, 418, 38-39. http://dx.doi.org/10.1038/418038a
|
[45]
|
Pan, Q., Henry, D., Metselaar, J., Scholte, B., Kwekkeboom, J., Tilanus, W., Janssen, L. and van der Laan, J. (2009) Combined Antiviral Activity of Interferon-Alpha and RNA Interference Directed against Hepatitis C without Affecting Vector Delivery and Gene Silencing. Journal of Molecular Medicine, 87, 713-722. http://dx.doi.org/10.1007/s00109-009-0470-3
|
[46]
|
Smith, M., Smolic, R., Volarevic, M. and Wu, Y. (2007) Positional Effects and Strand Preference of RNA Interference against Hepatitis C Virus Target Sequences. Journal of Viral Hepatitis, 14, 194-212. http://dx.doi.org/10.1111/j.1365-2893.2006.00794.x
|